CTRI/2023/09/057235Not yet recruitingUnknown
The role of salivary Visfatin and IL-6 as potential predictive markers of Obstructive Sleep Apnea in Patients with coexisting stage III/IV Periodontitis and Obesity: an observational study - NI
Maajida Aafreen M0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Pristine periodontal health:
- •1 No bleeding on probing
- •2 Normal gingival sulcus depth
- •3 Normal bone heights
- •4 Controlled modifying factors
- •Clinical periodontal health (intact periodontium):
- •1 No or minimal bleeding on probing
- •2 Normal gingival sulcus depth
- •3 Normal bone heights
- •4 Controlled modifying factors
- •5 Controlled predisposing factors
- •Stage III periodontitis:
- •1 Interdental clinical attachment loss at site of greatest loss greater than or equal to 5mm
- •2 Radiographic bone loss extending to middle or apical third of root
- •3 Tooth loss due to periodontitis less than or equal to 4 teeth
- •4 Probing depth greater than or equal to 6mm.
- •5 Extent: Greater than 30 percentage of teeth involved (Generalized)
- •Stage IV periodontitis:
- •1 Interdental clinical attachment loss at site of greatest loss greater than or equal to 5mm
- •2 Radiographic bone loss extending to middle or apical third of root
- •3 Tooth loss due to periodontitis greater than or equal to 5 teeth
- •4 Extent: Greater than 30 percentage of teeth involved (Generalized)
- •Inclusion criteria for obesity:
- •According to Centers for Disease Control and Prevention(CDC):
- •BMI evaluation will be done by measuring the weight (in kgs) and height (in cms) to determine the body size.
- •With the metric system, the formula for BMI is weight in kilograms divided by height in meters squared.
- •30.0 to less than 35.0-Class 1 obesity
- •35.0 to less than 40.0-Class 2 obesity
- •40.0 or over-Class 3 obesity ( also known as morbid, extreme, or severely obese)
Exclusion Criteria
- •1 Patients with other systemic inflammatory conditions like diabetes, hypertension, chronic kidney disease, chronic respiratory infections, cancers, asthma, HIV and hepatitis will be excluded from the study
- •2 History of periodontal treatment within the previous 6 months
- •3 Smoking and alcohol consumption
- •4 Pregnant and lactating women
- •5 History of antibiotic therapy in the past 3 months
Investigators
Similar Trials
Completed
Not Applicable
Evaluation of salivary biomarkers for early detection of oral cancer and precancerous conditionsCTRI/2022/10/046302Vinayalekshmy I N Nair60
Completed
Not Applicable
The Role of Visfatin in Obesity and Periodontal DiseaseObesityPeriodontitisNCT03470987Gazi University50
Completed
Not Applicable
Evaluation of Salivary Biomarker Levels in Individuals With Different Periodontal ConditionsPeriodontal HealthPeriodontitisGingivitisNCT06558136Izmir Katip Celebi University60
Completed
Not Applicable
Serum and Saliva Sirtuin 6, Lipoxin A4, Caspase8 Levels in Correlation With Periodontal Status in Severe PeriodontitisPeriodontitisDiagnose DiseaseNCT05417061Istanbul Medipol University Hospital40
Completed
Not Applicable
Evaluation of Saliva IL-6 Levels and PeriodontitisPeriodontal DiseasesNCT04382105University of Messina287